I must disagree with my Foolish colleague W.D. Crotty's reading on Intuitive Surgical's
Pharmaceutical giants like Merck
Remember, too, the value proposition behind the price tag for Intuitive's da Vinci and its robotic-assisted minimally invasive surgeries:
- Faster recoveries.
- Lower risk of infection.
- Better physician control.
With a profile like that, insurance companies like WellPoint
I'll agree with W.D. that Intuitive Surgical's shares don't look cheap. World-changing companies like those profiled in David Gardner's Motley Fool Rule Breakers rarely do. Then again, Microsoft
The next revolutionary breakthrough is already out there, waiting to burst on to the scene. Click here to start your free trial to Rule Breakers, and be among the first to find out what it just might be. Subscribe today, and you'll also receive free access to Stocks 2006, the Fool's guide to the investing year ahead.
Wait! You're not done. This is just a quarter of the Duel! Don't miss the Bull and Bear opening arguments, as well as the Bearish rebuttal. Even when you're done, you're still not done. You can vote and let us know who you think won this Duel.
More from The Motley Fool
Spirit Airlines Raises Guidance: Will 2018 Be Even Better?
Spirit Airlines is recovering quickly from a damaging fare war with United. If Spirit can keep up the momentum, 2018 could be a great year for shareholders.
1 Major Threat Oracle Investors Can't Afford to Ignore
Some competitors are trying to bridge the moat surrounding its database dominance.
Will Apple Inc.'s Battery Replacement Program Hurt iPhone Sales?
One analyst thinks so.